Skip to main content

Ainos, Inc.

corporate_fare Company Profile

Ainos, Inc.

AIMD·NASDAQ·Technology·CIK 0001014763

Ainos, Inc., incorporated in Texas in 1984, is a dual-platform company focused on artificial intelligence-based smell technologies and immune therapeutics. The company's main strategic focus is commercializing its proprietary scent digitization platform, AI Nose. Concurrently, Ainos develops therapeutic assets from its low-dose oral interferon program, VELDONA®. AI Nose is an AI-based electronic olfaction system that combines gas sensor arrays with proprietary artificial intelligence models, called a smell language model (SLM), to convert scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format. Initially developed for healthcare settings, including point-of-care testing (POCT), AI Nose's sensor architecture, data models, and system calibration were shaped by these early applications. The company is now expanding AI Nose into industrial environments for real-time environmental sensing, anomaly detection, and operational monitoring. Current and planned industrial uses include semiconductor manufacturing, robotics, and smart manufacturing. Ainos believes AI Nose's scent digitization architecture is adaptable across various industrial and non-industrial sectors. Ainos is advancing AI Nose through partner-led deployments, focusing on platform scalability, data-driven performance improvement, and integration into existing industrial ecosystems. The company aims to expand scent's role as a machine-readable data alongside vision and sound. Separately, Ainos continues to develop VELDONA®, its low-dose oral interferon platform, for selected rare, autoimmune, and infectious diseases. VELDONA® programs include candidates for treating oral warts in HIV-positive patients, Sjögren's syndrome, and feline chronic gingivostomatitis (FCGS). Research and development activities for VELDONA® have been ongoing since the company's inception.

Ainos, Inc. (NASDAQ:AIMD) is a publicly traded company in the Technology sector. Wiseek has independently scored 36 items for AIMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for AIMD spans 8-K, 10-Q, DEF 14A, 424B5.

Recent high-impact activity:

  • Ainos Gets Nasdaq Deficiency Letter on $2.5M Equity Rule; 45 Days to File Plan
  • Ainos 10-Q: Going-Concern Warning and Nasdaq Equity Deficiency Disclosed
  • Ainos Q3 Revenue Jumps to $642,889, Net Loss Narrows 36%; $11M Convertible Notes Now Current
  • Q3 Revenue Jumps 29,567% to $642,889 as AI Nose Orders Convert to Sales
  • Ainos Lands Record $9M ASE Order for 5,000 AI Nose Systems, With $4.5M Deposit Due in 60 Days

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$124.16K
Net Income
-$14.77M
Diluted EPS
-$3.46
Op. Cash Flow
-$4.61M
Free Cash Flow
-$4.65M
Gross Profit
$102.91K
Operating Income
-$13.99M
Cash & Equivalents
$417.35K
Debt / Equity
0.00×
Net Margin
-118.97×
Shares Outstanding
5.88M sh
Source: 10-K · filed 2026-03-30 · accession 0001493152-26-013579

Short Interest & Short Volume

1.40 days to cover

FINRA reported short interest of 37,529 shares in AIMD as of the October 30, 2026 settlement, a 20.3% decrease from the prior period — about 1.4 days to cover at its recent average daily volume. On November 20, 2026, 39.9% of AIMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)37,529 shares as of October 30, 2026
Change vs prior period▼ 20.3%
Days to cover1.40 at avg daily volume of 26,829
Daily short volume (FINRA facilities)39.9% of 103,181 shares on November 20, 2026
5-day average short volume51.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for AIMD, detected from its recent SEC filings · based on capital-structure filings through 2026-07-24.

1 recent capital raiseATM program

ATM Program Upsized to $1.35M · $2.7M Already Sold Under Program

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with A →
$1.15 -2.54% today
52-week range · as of 2026-11-20 $0.434 – $3.88
Market cap
$8.93M
Volume
230.7K (0.1× avg)
3-mo avg 3.7M
Live data · 2026-11-21 17:25 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AIMD - Latest Insights

AIMD
Nov 20, 2026, 5:15 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.15
Real-time Price: $1.15 info
Change: $0 (0%) info
Market Cap: $8.927M info
AIMD
Nov 16, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.10
Real-time Price: $1.15 info
Change: +$0.050 (+5%) info
Market Cap: $8.927M info
AIMD
Nov 16, 2026, 8:41 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.32
Real-time Price: $1.15 info
Change: -$0.165 (-13%) info
Market Cap: $8.927M info
AIMD
Nov 16, 2026, 8:30 AM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $1.30
Real-time Price: $1.15 info
Change: -$0.150 (-12%) info
Market Cap: $8.927M info
AIMD
Nov 12, 2026, 8:30 AM EST
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $0.520
Real-time Price: $1.15 info
Change: +$0.630 (+121%) info
Market Cap: $8.927M info
AIMD
Nov 10, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.4693
Real-time Price: $1.15 info
Change: +$0.6807 (+145%) info
Market Cap: $8.927M info
AIMD
Sep 28, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.39
Real-time Price: $1.15 info
Change: -$0.238 (-17%) info
Market Cap: $8.927M info
AIMD
Sep 28, 2026, 8:00 AM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $1.32
Real-time Price: $1.15 info
Change: -$0.170 (-13%) info
Market Cap: $8.927M info
AIMD
Sep 24, 2026, 8:00 AM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $1.15 info
Change: -$0.350 (-23%) info
Market Cap: $8.927M info
AIMD
Sep 16, 2026, 11:00 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $1.37
Real-time Price: $1.15 info
Change: -$0.220 (-16%) info
Market Cap: $8.927M info
AIMD
Sep 14, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.15 info
Change: -$0.350 (-23%) info
Market Cap: $8.927M info
AIMD
Aug 03, 2026, 5:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.52
Real-time Price: $1.15 info
Change: -$0.370 (-24%) info
Market Cap: $8.927M info
AIMD
Aug 03, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.49
Real-time Price: $1.15 info
Change: -$0.340 (-23%) info
Market Cap: $8.927M info
AIMD
Jul 24, 2026, 12:16 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.52
Real-time Price: $1.15 info
Change: -$0.365 (-24%) info
Market Cap: $8.927M info
AIMD
Jul 10, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.89
Real-time Price: $1.15 info
Change: -$0.740 (-39%) info
Market Cap: $8.927M info
AIMD
May 20, 2026, 8:00 AM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $1.60
Real-time Price: $1.15 info
Change: -$0.450 (-28%) info
Market Cap: $8.927M info
AIMD
May 13, 2026, 5:15 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.85
Real-time Price: $1.15 info
Change: -$0.700 (-38%) info
Market Cap: $8.927M info
AIMD
May 13, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.85
Real-time Price: $1.15 info
Change: -$0.700 (-38%) info
Market Cap: $8.927M info
AIMD
May 13, 2026, 4:30 PM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $1.15 info
Change: -$0.500 (-30%) info
Market Cap: $8.927M info
AIMD
Apr 17, 2026, 4:20 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $1.15 info
Change: -$0.820 (-42%) info
Market Cap: $8.927M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets